opentargets-database

To identify and validate drug targets, you can query the Open Targets Platform to analyze target-disease associations, genetic evidence, tractability, and known drug information. This facilitates therapeutic hypothesis generation by integrating multi-modal biomedical data.

Yes, you can assess safety liabilities and druggability by querying the platform for integrated evidence on target tractability and safety. This allows you to evaluate the biological relevance and clinical precedence of candidate targets.

You can find existing drugs for repurposing by querying known drug information and target-disease associations. This identifies established therapies that interact with targets linked to new indications, streamlining the drug repurposing process.

This drug target discovery approach requires the Python requests library to function. It operates by programmatically querying the Open Targets Platform, so an active environment supporting standard HTTP requests is necessary.

The best way to generate therapeutic hypotheses for Alzheimer's is to query the platform for genes with strong genetic associations and known clinical precedence. This analyzes integrated genetic, omics, and literature data to prioritize targets.

A key limitation for target identification is that the platform provides integrated evidence for hypothesis generation rather than clinical validation. Users must independently verify genetic evidence, tractability, and safety liabilities before proceeding.